Product NDC: | 13632-123 |
Proprietary Name: | Soltamox |
Non Proprietary Name: | tamoxifen citrate |
Active Ingredient(s): | 10 mg/5mL & nbsp; tamoxifen citrate |
Administration Route(s): | ORAL |
Dosage Form(s): | LIQUID |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 13632-123 |
Labeler Name: | Rosemont Pharmaceuticals Ltd |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021807 |
Marketing Category: | NDA |
Start Marketing Date: | 20121001 |
Package NDC: | 13632-123-01 |
Package Description: | 1 BOTTLE in 1 CARTON (13632-123-01) > 150 mL in 1 BOTTLE |
NDC Code | 13632-123-01 |
Proprietary Name | Soltamox |
Package Description | 1 BOTTLE in 1 CARTON (13632-123-01) > 150 mL in 1 BOTTLE |
Product NDC | 13632-123 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | tamoxifen citrate |
Dosage Form Name | LIQUID |
Route Name | ORAL |
Start Marketing Date | 20121001 |
Marketing Category Name | NDA |
Labeler Name | Rosemont Pharmaceuticals Ltd |
Substance Name | TAMOXIFEN CITRATE |
Strength Number | 10 |
Strength Unit | mg/5mL |
Pharmaceutical Classes | Estrogen Agonist/Antagonist [EPC],Selective Estrogen Receptor Modulators [MoA] |